نتایج جستجو برای: روش csu

تعداد نتایج: 370049  

Journal: :Allergy and asthma proceedings 2016
Dennis Ledford Michael S Broder Evgeniya Antonova Theodore A Omachi Eunice Chang Allan Luskin

BACKGROUND Treatments for patients with chronic idiopathic urticaria (CIU)chronic spontaneous urticaria (CSU) who were unresponsive to antihistamines include oral corticosteroids (OCS). Risks of OCS-related side effects in these patients have not been described quantitatively. OBJECTIVE To investigate the relationship between OCS use and the risk of developing side effects possibly attributab...

2016
Ji-Hye Kim Hyung-Young Lee Ga-Young Ban Yoo-Seob Shin Hae-Sim Park Young-Min Ye

A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test for the detection of basophil histamine-releasing activity upon autoantibodies or autoreactive st...

Journal: :Clinical and vaccine immunology : CVI 2007
Baolin Wang Marcela Henao-Tamayo Marisa Harton Diane Ordway Crystal Shanley Randall J Basaraba Ian M Orme

A fusion protein designated CSU-F36 was constructed that consisted of acylated Rv1411, a potent Toll-like receptor-2 agonist, fused to ESAT-6, a well-characterized immunogenic protein from Mycobacterium tuberculosis. The CSU-F36 fusion protein strongly induced interleukin 12 secretion from macrophages and induced the increased accumulation of CD4 T cells capable of secreting gamma interferon in...

Journal: :European annals of allergy and clinical immunology 2017
G A Vena N Cassano

Summary Metabolic syndrome (MS) is a cluster of risk factors for cardiovascular disease and is considered a chronic low-level systemic inflammatory condition. Recent preliminary findings have shown an increased prevalence of MS among patients with chronic urticaria (CU) as compared to controls, with a particularly higher prevalence detected in patients with uncontrolled CU. Chronic spontaneous ...

Journal: :Arquivos brasileiros de endocrinologia e metabologia 2013
Rosaria Maddalena Ruggeri Giuseppe Vita Anna Grazia D'Angelo Paolina Quattrocchi Rosaria Certo Salvatore Benvenga Salvatore Cannavò Sebastiano Gangemi

Chronic spontaneous urticaria (CSU), defined as the occurrence of spontaneous wheals for more than six weeks, has been associated with autoimmune diseases. Herein, we report the unusual association of CSU, Graves' disease, and premature ovarian failure. Human leukocyte antigen (HLA) studies were performed. A 36-year-old woman presented symptoms and signs of hyperthyroidism for three months. In ...

Journal: :European annals of allergy and clinical immunology 2016
A S Cordeiro Moreira M I Rosmaninho Lopes de Soares E Silva M A Pereira Guilherme J A da Silva Ferreira J P Fonseca Moreira da Silva

BACKGROUND Omalizumab is indicated to treat chronic spontaneous urticaria (CSU) refractory to antihistamines. We aim to describe the experience of our department in the treatment of CSU with omalizumab. MATERIALS AND METHODS Retrospective review of the clinical records of patients. RESULTS Six patients (5 females, median age 33 years) treated with omalizumab for a median of 17.5 months were...

2014
Germán Gavilán Jose D. Salas Fernando R. Salas Pierre Y. Julien

Jose D. Salas is a professor emeritus of civil and environmental engineering at Colorado State University (CSU). He received BS and civil engineering degrees from the National University of Engineering of Lima, Perú; MSc degree in hydraulics; and PhD degree in hydrology and water resources from CSU. At CSU, he supervised (main advisor) 42 MSc and 37 PhD students. Dr. Salas has been consultant o...

2017
A.Y. Finlay A.P. Kaplan L.A. Beck E.N. Antonova M.‐M. Balp J. Zazzali S. Khalil M. Maurer

BACKGROUND Chronic spontaneous/idiopathic urticaria (CSU/CIU) has substantial detrimental effects on health-related quality of life (HRQoL) with an effect comparable to or worse than many other skin diseases. OBJECTIVE To assess the effect of omalizumab on CSU patients' HRQoL, measured by the Dermatology Life Quality Index (DLQI) in three phase III studies ASTERIA I, ASTERIA II and GLACIAL. ...

Journal: :Zeitschrift für Parlamentsfragen 2013

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید